Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Haemonetics Corp (HAE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,540,400
  • Shares Outstanding, K 51,007
  • Annual Sales, $ 903,920 K
  • Annual Income, $ 45,570 K
  • 36-Month Beta 0.89
  • Price/Sales 4.96
  • Price/Cash Flow 24.81
  • Price/Book 7.06

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate 0.55
  • Number of Estimates 5
  • High Estimate 0.57
  • Low Estimate 0.52
  • Prior Year 0.43
  • Growth Rate Est. (year over year) +27.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
82.28 +7.71%
on 02/08/19
100.52 -11.84%
on 01/22/19
-12.30 (-12.19%)
since 01/18/19
3-Month
82.28 +7.71%
on 02/08/19
109.45 -19.03%
on 12/03/18
-13.56 (-13.27%)
since 11/21/18
52-Week
68.91 +28.60%
on 02/22/18
117.56 -24.61%
on 10/01/18
+19.75 (+28.68%)
since 02/21/18

Most Recent Stories

More News
Consolidated Research: 2019 Summary Expectations for Corning, Windstream, Deckers Outdoor, Haemonetics, The Descartes Systems Group, and CSG Systems International -- Fundamental Analysis, Key Performance Indications

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Corning Incorporated (NYSE:GLW),...

DSGX : 33.79 (+0.72%)
GLW : 34.50 (-0.46%)
CSGS : 41.65 (+1.81%)
DECK : 143.26 (-0.35%)
WIN : 0.95 (-25.97%)
HAE : 88.62 (-0.44%)
Haemonetics (HAE) Earnings Top, Revenues Lag Estimates in Q3

Haemonetics' (HAE) year-over-year earnings growth in Q3 is backed by benefits from complexity reduction and investments along with strength in market demand and success from early launches.

VAR : 131.71 (-0.70%)
ANGO : 22.43 (-4.31%)
HAE : 88.62 (-0.44%)
CNMD : 75.14 (+1.93%)
Look for Shares of Haemonetics Corp to Potentially Rebound after Yesterday's 9.05% Sell Off

Haemonetics Corp (NYSE:HAE) traded in a range yesterday that spanned from a low of $85.45 to a high of $88.38. Yesterday, the shares fell 9.0%, which took the trading range below the 3-day low of $96.05...

HAE : 88.62 (-0.44%)
Haemonetics (HAE) Q3 Earnings Surpass Estimates

Haemonetics (HAE) delivered earnings and revenue surprises of 6.78% and -1.14%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

HAE : 88.62 (-0.44%)
Haemonetics: Fiscal 3Q Earnings Snapshot

BRAINTREE, Mass. (AP) _ Haemonetics Corp. (HAE) on Tuesday reported fiscal third-quarter net income of $18.3 million, after reporting a loss in the same period a year earlier.

HAE : 88.62 (-0.44%)
Haemonetics 3rd Quarter Fiscal 2019 Earnings Release Available on Investor Relations Website

Haemonetics Corporation (NYSE:HAE) announced that its third quarter and year-to-date fiscal 2019 results ended December 29, 2018 are available on its Investor relations website.

HAE : 88.62 (-0.44%)
Analysts Estimate Haemonetics (HAE) to Report a Decline in Earnings: What to Look Out for

Haemonetics (HAE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

HAE : 88.62 (-0.44%)
Perrigo Stock Up as Appeal Date for Irish Tax Bill Nears

Perrigo's (PRGO) shares rebound as the time to file an appeal against the Irish tax bill of $1.9 billion nears its deadline of Dec 28.

ATRC : 32.78 (-0.91%)
HAE : 88.62 (-0.44%)
PRGO : 48.32 (-1.27%)
BIIB : 321.17 (-4.17%)
Perrigo Plunges on $1.9B Tax Bill From Irish Government

Perrigo (PRGO), in a SEC filing, reports a $1.9 billion tax bill from Irish revenue department related to its subsidiary, Elan Pharma.

ATRC : 32.78 (-0.91%)
HAE : 88.62 (-0.44%)
PRGO : 48.32 (-1.27%)
BIIB : 321.17 (-4.17%)
Haemonetics Sets Date for Publishing Third Quarter Fiscal 2019 Results: February 5, 2019

Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish third quarter fiscal 2019 financial results at 6:00 am EST on Tuesday, February 5, 2019. The Company will hold a conference...

HAE : 88.62 (-0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Trade HAE with:

Business Summary

Haemonetics Corporation is a Global Leader in Blood Management Solutions. Their comprehensive portfolio of devices, information management, consulting services offers blood management solutions for each facet of the blood supply chain from plasma blood collectors to hospitals. They believe that through...

See More

Key Turning Points

2nd Resistance Point 89.91
1st Resistance Point 89.26
Last Price 88.62
1st Support Level 88.12
2nd Support Level 87.63

See More

52-Week High 117.56
Fibonacci 61.8% 98.97
Fibonacci 50% 93.23
Last Price 88.62
Fibonacci 38.2% 87.49
52-Week Low 68.91

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar